Sodium Phosphates Injection, Solution
Product Images NDC 0517-7315

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Sodium Phosphates (NDC 0517-7315). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Regent, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Arl Logo (Sodium Phosphates Injection Anda 1)

Arl Logo (Sodium Phosphates Injection   Anda 1)
This text contains contact information for American Regent, Inc. located in Shirley, NY 11967.*
FDA Label Image

Container Label (5 mL) (Sodium Phosphates Injection Anda 2)

Container Label (5 mL) (Sodium Phosphates Injection   Anda 2)
This is a description of Sodium Phosphates Injection, USP, a sterile and nonpyrogenic medication indicated for intravenous use. It must be diluted before administration. Each 5 mL single-dose vial contains monobasic sodium phosphate and dibasic sodium phosphate. The solution has an osmolarity of 7 mOsmol/mL and contains no more than 180 mcg/L of aluminum. The storage temperature is 20° to 25°C. For specific dosage information, refer to the insert provided by American Regent, Inc.*
FDA Label Image

Carton Labeling (5 mL)

Carton Labeling (5 mL)
This product is a 5 mL Single-Dose Vial of Sodium Phosphates Injection, USP. It contains monobasic sodium phosphate and dibasic sodium phosphate. It has a calculated osmolality of 7 mOsmol/L and a pH of 5.5. The vial should be used promptly once opened and any unused portion should be discarded. It should be stored at 20°C to 25°C. This product is for intravenous use and must be diluted before administration. Manufacturer: American Regent, Inc.*
FDA Label Image

Container Label (15 mL)

Container Label (15 mL)
This is a description of Sodium Phosphates Injection, USP, which is intended for intravenous use. Each 15 mL single-dose vial contains 45 mM P/15 mL and 60 mEq Na*/15 mL. It is important to dilute before use and discard any unused portion. The solution is sterile, nonpyrogenic, and contains no more than 180 mcg/L of aluminum. It should be stored at 20° to 25°C (68° to 77°F). The product is manufactured by American Regent, Inc. and the usual dosage information can be found in the insert.*
FDA Label Image

Carton Labeling (15 mL)

Carton Labeling (15 mL)
This text describes a 15 mL single-dose vial of Sodium Phosphates Injection, USP with concentrations of 45 mM P/mL and 60 mEq Na*/15 mL. It provides instructions to discard unused portions and emphasizes the importance of dilution for intravenous use. Additionally, it includes safety cautions and an NDC code for prescription use.*
FDA Label Image

Container Label (50 mL)

Container Label (50 mL)
This is a description of Sodium Phosphates Injection, a medication indicated for intravenous use. Each 50mL vial contains 150mM of phosphate and 200 mEq of sodium. The solution must be diluted before administration. Each mL contains monobasic and dibasic sodium phosphates. It is sterile, nonpyrogenic, with low aluminum content. It should be stored at room temperature. The manufacturer is American Regent, Inc. Dosage instructions are provided in the insert.*
FDA Label Image

Carton Labeling (50 mL)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.